Wednesday, 1 December 2021
Investor Ideas #Potcasts 615, #Cannabis News and #Stocks on the Move; Interview with President & CEO of Flora Growth Corp (NASDAQ: $FLGC)
Investor Ideas #Potcasts
615, #Cannabis News and #Stocks on the Move; Interview with President & CEO
of Flora Growth Corp (NASDAQ: $FLGC)
Delta, Kelowna, BC, December 1, 2021 (Investorideas.com
Newswire) www.Investoride, as.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/120121-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/12011Interview-FLGC.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast Investorideas interviews Luis
Merchan, President & CEO of Flora Growth Corp. (NASDAQ: FLGC), where we discussed the recent
move by JP Morgan to stop trading on some cannabis stocks and how this impacts
the industry, how Flora Growth has developed as an international cannabis
company as well as how the industry is expanding internationally.
Luis Merchan, President and CEO of Flora Growth Corp., is a New
York & Miami-based executive with over a decade of proven experience in
enterprise sales management, corporate strategy, merchandising and expense
management, and customer experience. During Luis’ term as Flora CEO, the
company has added over 10,000 new investors, went public on the Nasdaq in May
2021, and now organized to support a portfolio of organic cannabis-based
products rapidly growing through acquisitions and partnerships.
Flora Growth Corp most recently signed a licensing agreement with luxury goods brand Tonino Lamborghini to sell cannabidiol-infused beverages in North America and Colombia.
The two companies will first launch
coffee infused with cannabidiol (CBD), a non-psychoactive compound of cannabis
that has found increased use as a relaxative.
"The cannabis market represents
a very interesting niche and we intend to offer a different luxury
experience," Tonino Lamborghini Chief Executive Officer Ferruccio
Lamborghini, whose grandfather founded the supercar brand, said in an email. He
added that his company has been in the coffee sector for over 30 years, with a
line of premium espresso blends.
Tonino Lamborghini is not affiliated
with the carmaker, now a unit of Volkswagen, but run by members of the
Lamborghini family.
Merchan discussed some of the
company’s other more recent announcements such as the recent acquisition of 100% of Vessel Brand Inc. for aggregate consideration of US$30M, consisting
of a combination of cash and the issuance of Flora common shares, their agreement with SHOWFIELDS to feature its two skincare brands, MIND Naturals
and Awe (Ô), at its flagship location in South Beach, Miami, as well as through
its online store as well as their agreement with with GlossWire to feature its two skincare
brands, MIND Naturals, and Awe (Ô), on GlossWire's digital beauty marketplace.
Flora Growth is the operator of one
of the largest outdoor cannabis cultivation facilities and Flora leverages
natural, cost-effective cultivation practices to supply cannabis derivatives to
its diverse business divisions of cosmetics, hemp textiles, and food and
beverage.
When asked about Flora’s production
coming out of Colombia, Merchan commented, “when you compare North American
cannabis cultivators to those of cultivators along the equator, you’re talking
about a cost efficiency comparison of about twenty-five times. Colombia has a
seasonless geography and an agricultural know-how that has existed for decades.
Cannabis is considered a specialty cut flower and in the 1990’s there was a
boom in specialty cut flowers South America and Colombia became the number one producer of cut flowers in
the world and that is still true today. It is one of the number two
exporters of flowers in the world and 70% of all the flowers that come into the
U.S. come from Colombia. When you combine these factors, agricultural know-how,
geography and cost, you’re able to reach production costs that cannot be
compared with North America. At Flora we have reached a production cost of
$0.06 per gram for dried flower, compared to over $1.00 from North American
counterparts. It’s important to highlight that we are also doing so with the
highest standards of quality, GACP certified, observing organic practices which
will help us become a global cannabis player in the short term.”
Merchan went on to discuss how he
expects this industry to evolve both internationally and domestically in the
U.S., how the company’s acquisition of Vessel is expected to strengthen Flora’s
growth and development and how specifically Flora has helped separate
themselves from some of their competitors.
Visit www.floragrowth.com
or follow @floragrowthcorp on social for more information.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com
podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Tuesday, 30 November 2021
Investor Ideas #Potcasts 614, #Cannabis News and #Stocks on the Move; (TSX: $FAF.TO) (OTCQX: $FFLWF), (TSX: $AVCN.TO) (OTCQX: $AVCNF), (CSE: $LUV.C)
Investor Ideas #Potcasts
614, #Cannabis News and #Stocks on the Move; (TSX: $FAF.TO) (OTCQX: $FFLWF),
(TSX: $AVCN.TO) (OTCQX: $AVCNF), (CSE: $LUV.C)
Delta, Kelowna, BC, November 30, 2021 (Investorideas.com
Newswire) www.Investoride, as.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/113021-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/11301FAF-AVCN-LUV.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few private and public company announcements.
But
first, the big news internationally over the last two weeks has been from Germany
as the leaders of Germany’s incoming governing parties announced that they have a formal agreement to
legalize marijuana and promote broader drug policy harm reduction measures when
they take power.
“We are introducing the controlled
supply of cannabis to adults for consumption in licensed stores,” the parties
said in a new 118-page agreement, according to a translation. “This controls
the quality [of marijuana], prevents the transfer of contaminated substances
and guarantees the protection of minors.”
As it stands, personal possession of
marijuana is decriminalized in Germany, and there is a medical cannabis program
in place. But this proposal seeks to establish a regulated market for adult-use
marijuana.
The joint government will review the
social impact of legalization four years after implementation.
Beyond cannabis legalization, the so-called
traffic light coalition will also advance other drug policy reforms such as
establishing drug-checking services where people can have illicit drugs tested
for contaminants and other harmful substances without fear of facing criminal
sanctions.
The governing coalition—comprised of
the Social Democratic Party of Germany (SPD), the Free Democratic Party (FDP)
and the Greens—also said that the legislation will restrict advertising for
marijuana, alcohol and tobacco products.
Fire
& Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF),
a leading, technology-powered, cannabis retailer announced that, in connection with the
potential additional listing of the common shares in the capital of the Company
on the Nasdaq, it has filed articles of amendment implementing a consolidation
of the Shares on the basis of ten (10) pre-consolidation Shares for every one
(1) post-consolidation Share. The Consolidation was previously approved by the
Company's shareholders at its annual and special meeting of shareholders held
on June 9, 2021.
Trevor Fencott, Chief Executive
Officer of Fire & Flower commented, "The share consolidation is an
important step in our U.S. expansion strategy. It enables Fire & Flower to
qualify for a listing on the NASDAQ and expand its shareholder base which, in
turn, provides the Company with increased flexibility and enhanced liquidity to
accelerate its strategic growth plans."
"We have built an
industry-leading cannabis consumer technology platform and, as demand for our
technology platform continues to build in the U.S., now is the right time to
advance our NASDAQ listing and make our shares more accessible to a larger
investor audience."
"Along with our previously
announced acquisitions of trusted cannabis strain information destination,
Wikileaf (www.wikileaf.com)
and best-in-class dispensary, culture and cannabis marketplace, PotGuide in
Denver, Colorado (www.potguide.com),
the share consolidation is the next important step in our U.S. expansion
strategy. We look forward to completing the listing in the upcoming weeks as we
announce continued growth of our cannabis consumer technology platform and execution
on our asset-light business model," said Trevor Fencott, CEO of Fire &
Flower.
Eco
Farm Holdings PBC/ Thrive Society, a technology-forward portfolio of
operating assets in cannabis cultivation, manufacturing and consumer brands
that is unified through a distribution platform and powered by an upstream
digital marketplace, announced that its leading distribution
platform, which connects cannabis farmers with buyers across the state of
California, now supports over 400 cannabis farmers and 200 buyers including distributors,
manufacturers, and retailers. The achieved milestone positions Thrive Society
as one of the largest data driven, digitally connected supply chains of legal
cannabis in the world.
Operating in California, one of the
largest legal cannabis markets in the world with projected sales reaching $7.2
billion in the state by 2024, Thrive Society is a membership-based cannabis
distribution platform with a core mission to deliver a more effective farming
life cycle and route-to-market by leveraging Agriculture 4.0 technology and
focusing on precision agriculture, the internet of things (IoT) and the use of
big data to bring greater efficiencies and visibility to its upstream cannabis
member-cultivators and downstream member-buyers. Leveraging thousands of data
points, Thrive Society empowers farmers to sell cannabis in bulk to buyers with
confidence that the market value for their product is competitive – providing a
much-needed solution to the marketplace’s existing inconsistent pricing
structure. Thrive Society members receive priceless insight into harvesting and
demand trends, allowing growers to forecast cultivation strategies in real
time. For buyers, Thrive Society offers a real-time marketplace of an extensive
library of wholesale cannabis available for sale throughout the state,
eliminating stock-out issues and increasing price transparency.
“In every industry, data is king,”
said Devin Calloway, co-CEO, Founder and CTO of Eco Farm. “So many operators
are flying blind when it comes to harvest planning, price forecasting and
inventory management. Our platform, which is fueled by actual transaction
metrics that are occurring in real time, offers both sellers and buyers the
invaluable information they need to make data-driven operational decisions,
mitigate risk and increase profit margins.”
With two showrooms in Los Angeles
and Santa Rosa, Thrive Society members are able to list their cannabis products
for sale. Showcased products can range from dried flower to concentrates,
including product test results, batch information on the product and its
availability, and users can post a fair and transparent price, something not
seen in most distribution models currently employed throughout the industry.
Thrive Society operates under a community membership model where support of
mutually beneficial transactions is core to the Company’s ethos.
“Many cannabis businesses still rely
on antiquated supply chain systems. Leveraging our years of experience in the
cannabis industry, we have built a tech-forward infrastructure model throughout
California’s cannabis supply chain that allows us to operate in an efficient
and transparent way,” said Danielle Dao, co-CEO and Founder of Eco Farm.
“Achieving this milestone of supporting over 600 cannabis operators in the
world’s largest cannabis market is a true illustration of the potential
national success of our model, which is powered by technology.”
While Thrive Society is one of the
largest revenue-generating and innovative segments of the Company, Eco Farm is
a portfolio of holdings comprised of operating assets in genetics, cultivation,
manufacturing, and consumer brands. Through the Company’s licensed nursery
facility and relationships with preferred nursery partners, the Company offers
hundreds of genetic varieties of popular cultivars with unparalleled
consistency. Genetics remain one of the most important pieces of the cannabis
supply chain and leveraging this integrated approach allows Eco Farm to own and
control one of the most volatile pieces of the supply chain.
Eco Farm’s highly successful
cannabis consumer brand, Lifted Legacy, supports family-owned craft farms in
the Emerald Triangle and brings high-quality cannabis cultivars to market.
The Lifted Legacy brand is sold in over
75 retail shops throughout California and offers products that are
region-specific and chosen through data provided by the Thrive Society
platform. Rounding out the vertical integration of Eco Farm is the Company’s
highly scalable manufacturing facility, where the Company processes cannabis
products for its own brands as well as countless brands sold throughout the
state. The entire portfolio is powered by Eco Farm’s world-class technology and
plant-touching platforms, including Thrive Society, which is uniquely
positioned as a scalable model for emerging markets across the country.
Eco Farm is a public benefit
corporation, meaning the Company considers additional stakeholders in its
decision-making process besides the traditional economic benefit of its
shareholders. Stakeholders could include the community in which the Company
operates, the environment as it is impacted by the operations of the business,
or its staff and the overall benefit of their involvement in the organization.
While this designation adds an additional layer of complexity to the Company’s
operations, it was chosen as a way to add tangible metrics to the Company’s
mission of driving change through intent and action. The Company is led and
staffed by people from all backgrounds and constantly supports social equity
programs throughout the industry.
Avicanna
Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company
focused on the development, manufacturing, and commercialization of
plant-derived cannabinoid-based products, announced that it has entered into a
partnership with an established Argentine pharmaceutical company to register
and commercialize Avicanna’s proprietary cannabinoid-based pharmaceutical
preparations through the licensing of its intellectual property and supply of
its active pharmaceutical ingredients (“API”).
Through the partnership Avicanna
will provide a non-exclusive license of the Company’s intellectual property
related to its proprietary 10% cannabidiol (“CBD”) pharmaceutical drug
preparation. Additionally, the partner will source its pharmaceutical-grade CBD
exclusively from Avicanna to manufacture the product for the registration and
marketing authorization with the Argentine regulatory agency ANMAT.
The marketing authorization of the
pharmaceutical preparation is expected to be approved during the second half of
2022 and is expected to be supported with claims related to treatment of epilepsy.
The estimated patient population and market potential for epilepsy in Argentina
is between 400,000 to 500,000 patients of which about 20,000 patients have
refractory epilepsy. “We look forward to entering the Argentine market through
a pharmaceutical pathway and to be doing so by delivering our proprietary
formulations as solution to patients with unmet medical needs. We are rapidly
expanding into the region with innovative and accessible cannabinoid-based
pharmaceutical products and are doing so through partnership with reputable
industry leaders,” stated Lucas Nosiglia, President of Avicanna LATAM.
Love
Pharma Inc. (CSE: LUV) ,a Vancouver, Canada-based company,
which operates as a specialized health and wellness company that licenses and
distributes psychedelic and cannabis-infused products, has established a
practice of offering proven products with clinical data, user studies, and
scientific research to support its claims.
It’s a practice that gives Love Pharma a distinct market advantage over
many of its competitors. And now, Love
Pharma is set to broaden that advantage with its recent announcement that the company has
signed a Letter of Intent to acquire MicroDoz Therapy, Inc.
The benefit of this acquisition to
Love Pharma, its shareholders and worldwide consumers is that the company gains
MicroDoz’s exclusive partnership with a world-renowned university to conduct a
landmark study into the efficacy of psilocybin assisted treatment of cannabis
use disorder. Love Pharma can leverage
this relationship to further expand its product lineup, strengthen its clinical
validation program, and add to its comprehensive portfolio of intellectual
property.
Specifically, the acquisition will
further substantiate the company’s efforts to become a frontrunner in the
psychedelics and therapeutics space.
Love Pharma’s Chief Executive Officer (CEO), Zach Stadnyk, said his
company’s existing portfolio, which consists of the exclusive rights to 7 novel
therapeutic products focused on mental and sexual wellness, is already at the
leading edge of innovation in the industry.
So, continued new product development will further build upon what is
already a strong foundation. Stadnyk’s
goal is to establish a growing and loyal customer base as the company seeks to
define the psychedelics and therapeutics industry with solid science that leads
to effective products.
When explaining the acquisition of
MicroDoz Therapy, the CEO stated, “Science and efficacy are paramount to our
strategy, as a result we seized the opportunity to acquire MicroDoz to expedite
what will be a landmark study with a world-leading university.”
As an entry point into the
burgeoning psychedelics market, the company acquired the rights to the patent-pending
psilocybin strip in addition to the acquisition of MicroDoz, which has the
exclusive partnership to the landmark study at an unnamed leading global
university. Love Pharma announced it
expects to release the university’s name along with details of the program when
the definitive agreement is close.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com
podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Monday, 29 November 2021
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...